This NDC is on FDA's drug shortage list (posted Oct 12, 2022)

Reported reason: Shortage of an active ingredient

Product Information

DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Epic Pharma LLC, priced at $0.2841 per EA under NDC 42806034501. Its NADAC has been published 424 times since Oct 10, 2018.

FDA first approved this application on Jun 19, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1

Manufacturer

Epic Pharma LLC

NDC

42806034501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA040444

FDA Approved

6/19/2002

TE Code

AB

On Market Since

8/17/2018

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 424 times since Oct 10, 2018, and over the history we have for it it has declined 49.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2841 per EA
All-time high$0.5621 (Oct 10, 2018)
All-time low$0.2416 (Jul 17, 2024)
52-week high$0.3153
52-week low$0.2841
Median price$0.3270
Average price$0.3556
Largest weekly change-26.9% (Nov 20, 2024)
Weeks tracked424
Tracking sinceOct 10, 2018

Price History

1W

-2.0%

1M

-3.9%

3M

-6.3%

6M

-7.1%

1Y

-6.5%

3Y

-13.1%

5Y

-9.3%

All

-49.5%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Epic Pharma LLC, is $0.2841 per EA (NDC 42806034501), effective Nov 18, 2026.

How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 49.5%. It has been tracked across 424 weekly CMS publications since Oct 10, 2018.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?

Since Oct 10, 2018, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2416 (Jul 17, 2024) to a high of $0.5621 (Oct 10, 2018), with a median of $0.3270 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAMIN 30 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?

DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 42806034501) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.

Is DEXTROAMP-AMPHETAMIN 30 MG TAB in shortage?

Yes — NDC 42806034501 is currently listed in FDA's drug shortage database (posted Oct 12, 2022). Reported reason: Shortage of an active ingredient.